SCYNEXIS

SCYNEXIS Altman Z-Score

The Altman Z-Score of SCYNEXIS (SCYX) as of Oct 19, 2026 is -7.73. In the previous year, Altman Z-Score was -6.59 — a change of 17.18% (lower).

Altman Z-Score

-7.73

YoY

17.18%

Last updated:

Altman Z-Score of SCYNEXIS is 2025 -7.73 . Altman Z-Score of SCYNEXIS was 2024 -6.59 . It decreases by 17.18% lower compared to the previous year.

The SCYNEXIS Altman Z-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Altman Z-Score
Date
Altman Z-Score
Jan 1, 2018
-6.73 USD
Jan 1, 2019
-9.20 USD
Jan 1, 2020
-5.91 USD
Jan 1, 2021
-5.52 USD
Jan 1, 2022
-9.67 USD
Jan 1, 2023
-0.57 USD
Jan 1, 2024
-6.59 USD
Jan 1, 2025
-7.73 USD
The SCYNEXIS Altman Z-Score history
YEARAltman Z-ScoreYoY
-7.73+17.18%
-6.59+1,049.58%
-0.57-94.07%
-9.67+75.11%
-5.52-6.45%
-5.91-35.78%
-9.20+36.69%
-6.73-8.87%
-7.38+45.13%
-5.09+42.07%
-3.58+55.16%
-2.31—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Altman Z-Score of SCYNEXIS is -7.73 in 2025.

On Eulerpool you can find the complete historical development of Altman Z-Score SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

The Altman Z-Score predicts bankruptcy probability using five financial ratios. Scores above 3.0 indicate safety, below 1.8 suggests distress risk.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — SCYNEXIS

All Key Metrics — SCYNEXIS